ANZBMS 2026
Chairs: Grahame Elder & Mary Louise Fac
Patterns of osteoporosis treatment initiation following low-trauma fracture: an Australian population-based cohort study (#5)
10:45 AM
Repurposing FDA-Approved Drugs Targeting OXR1 to Suppress Osteoclastogenesis and Prevent Bone Loss (#6)
11:00 AM
Paternal occupational and household exposures during pregnancy; is there an association with offspring adult bone health and body composition? (#7)
11:15 AM
Preterm piglets as a translational large-animal model of osteopenia of prematurity (#8)
11:30 AM
Hypophosphataemia following parenteral iron and antiresorptives in clinical practice (#9)
11:45 AM
Using single-cell transcriptomics to identify gene regulatory networks involved in rare skeletal disorders (#10)
12:00 PM
Rethinking long‑term denosumab therapy: extending treatment intervals in low‑risk patients (#11)
12:15 PM
Central dopaminergic lesion induces asymmetrical femoral deterioration that becomes bilateral with limited oestrogen production (#12)
12:30 PM